ALXO: ALXオンコロジー・ホールディングス

ALXO News

• 13:55 bioAffinity Stock Surges 113.8% in 3 Months: What's Driving the Rally?
• 15:10 ALDX Crashes 71% as FDA Issues Third CRL for Dry Eye Disease Drug NDA
• 14:40 CTMX Stock Rallies on Strong Phase I Colorectal Cancer Study Data
• 17:35 IBRX Stock Jumps on Progress in NK Cell Therapy Production
• 16:59 JNJ's Bladder Cancer Therapy Meets Key Goal in Early-Stage Study
• 15:24 Allogene Therapeutics Posts Narrower-Than-Expected Loss in Q4
• 13:40 Is ADC Therapeutics (ADCT) Outperforming Other Medical Stocks This Year?
• 12:23 RARE's DTX301 Meets First Key Goal in Phase III OTC Deficiency Study
• 17:05 RLMD Stock Surges 42% in a Week: Here's What You Should Know
• 15:38 GSK Out-Licenses Rights for Rare Liver Disease Drug to Alfasigma
• 15:09 EDIT Stock Up on Narrower-Than-Expected Q4 Loss, Revenues Rise Y/Y
• 14:23 Roche's Giredestrant Misses Key Goal in First-Line Breast Cancer Study
• 15:26 LRMR Stock on the Move: What Sparked the 55% Jump in the Past Month?
• 14:57 QURE Stock Crashes 32% in a Week: Here's What You Should Know
• 13:27 Mirum Completes Enrollment & Screening in Liver Disease Studies
• 14:18 CANF Stock Soars 20% on Positive Mid-Stage Pancreatic Cancer Data
• 10:07 ACAD Plans Re-Examination After CHMP Rejects Rett Syndrome Drug in EU (Revised)
• 13:03 ACAD Plans Re-Examination After CHMP Rejects Rett Syndrome Drug in EU
• 14:15 ALX Oncology: Evorpacept For ASPEN-09 Presses On With 2 Key Milestones (NASDAQ:ALXO)
• 19:00 Brightspring Health Services, BASF, Swiss Re and more set to report Friday
• 14:40 Is Teva Pharmaceutical Industries (TEVA) Outperforming Other Medical Stocks This Year?
• 14:40 Is ALX Oncology Holdings (ALXO) Stock Outpacing Its Medical Peers This Year?
• 13:48 ALXオンコロジー、1株1.57ドルで1億5000万ドルの株式公募価格を決定
• 13:47 ALX Oncology prices $150 million stock offering at $1.57 per share